Boston Scientific to Acquire Apollo Endosurgery for $615 Million
November 30, 2022
Boston Scientific Corporation has entered into a definitive agreement to acquire Apollo Endosurgery for $615 million in cash (approximately $10 per share). The deal expands Boston Scientific’s endoluminal surgery (ELS) capabilities and adds an adjacency into the endobariatric market.
- Targets
- Apollo Endosurgery
- Industry
- Medical Devices
- Location
- United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.